MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Cardiac Dysautonomia in Parkinson’s Disease

    A. Carwin, S. Miri, S. Nakano, M. Anjum, E. Mundel, J. Starr, C. Marsh, B. Wilmarth, M. Arellano, H. Howard, M. Hebron, Y. Torres-Yaghi, C. Moussa, F. Pagan (Washington, DC, USA)

    Objective: The aim of this study is to perform a preliminary investigation of the prevalence of cardiac autonomic dysfunction in newly diagnosed Parkinson’s patients. We…
  • MDS Virtual Congress 2020

    Autonomic symptoms as biomarkers in REM Sleep Behavior Disorder and Parkinson’s disease

    W. Hermann, L. Ecke, D. Wittig, D. Hausbrand, M. Brandt, H. Reichmann, A. Storch, T. Ziemssen (Dresden, Germany)

    Objective: This study was designed to evaluate autonomic functions in iRBD compared to PD and controls including longitudinal follow-up assessments to evaluate their potential to…
  • MDS Virtual Congress 2020

    Triggers and Alleviating Factors for Fatigue in Parkinson’s Disease

    I. Lin, B. Edison, S. Mantri, M. Daeschler, K. Kopil, C. Marras, L. Chahine (Pittsburgh, PA, USA)

    Objective: To examine self-reported triggers of fatigue for individuals with Parkinson’s Disease (PD), the strategies they employ to cope with fatigue, and the types of…
  • MDS Virtual Congress 2020

    Functional Hearing Impairment Common In Parkinson’s Disease: Insights From A Pilot Study

    D. Nene, M. Choi, A. Yu, M.S Mirian, J.A Small, L.M Jenstad, S. Appel-Cresswell (Vancouver, BC, Canada)

    Objective: The primary objective of this pilot study was to investigate hearing and its relationship to the neuropsychiatric profile, cognition and quality of life in…
  • MDS Virtual Congress 2020

    Early life stress offers a window into the relationship between depression and Parkinson’s disease: A 60-week study after maternal separation in rats

    C. Ren, K.J He, Y.T Zhang, J.B Zhang, F. Wang, C.F Liu (Suzhou, China)

    Objective: The aim of this study was to examine the relationship between depression and Parkinson's disease (PD) using the rat model of maternal separation (MS).…
  • MDS Virtual Congress 2020

    Prevalence of dysphagia and screening tools in patients with Parkinson’s disease

    H. Téllez-Lucero, O. Cárdenaz-Saenz, F. Herrera-Rodríguez, E. Escobar-Valdivia, A. Abundes-Corona, O. Esquivel-Zapata, Y. Ríos-Solís, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: Determine the prevalence of dysphagia in patients with Parkinson's disease (PD) and compare the Swallowing Disturbance Questionnaire (SDQ) and Eating Assessment Tool (EAT-10). Background:…
  • MDS Virtual Congress 2020

    Phenotype of Parkinson’s Disease in African Americans Using NIH Toolbox Motor Measures

    M. Bailey, G. Stebbins, S. Anderson, D. Hall (Chicago, IL, USA)

    Objective: To determine phenotypic differences using qualitative and quantitative measures between African American (AA) and white (W) patients with Parkinson’s disease (PD) at Rush University…
  • MDS Virtual Congress 2020

    Relationship between tumor and very slow Parkinson`s disease progression

    H. Mori (Kurashiki, Okayama, Japan)

    Objective: We evaluate the Parkinson`s disease patients with very slow progression. One of their clinical features are the medical history of tumor. Background: Some cancer…
  • MDS Virtual Congress 2020

    Dietary and Plasma Polyunsaturated Fatty Acids in Parkinson’s Disease

    D. Yoo, Y. Lim, T. Ahn (Seoul, Republic of Korea)

    Objective: We assessed the dietary intakes and plasma levels of polyunsaturated fatty acid (PUFA) in Parkinson's disease (PD), and their relation to motor and non-motor…
  • MDS Virtual Congress 2020

    Homer1 polymorphism in patients with Parkinson’s disease and psychosis

    A. Lenka, S. Vadivel, R. Christopher, S. Arumugham, S. Hegde, R. Yadav, P. Pal (Washington, DC, USA)

    Objective: To explore the association of psychosis in Parkinson’s disease with polymorphisms of HOMER1, a gene whose product (Homer1) is responsible for modulating the metabotropic…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #24970 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley